Alzheimer’s disease is the most common type of dementia. It is a progressive disease that starts with mild cognitive decline and can affect cognitive abilities, memory, thinking, and behavior. Alzheimer’s worsens over time and causes the brain to shrink and brain cells to eventually die. It is caused by damage to nerve cells (neurons) in the brain. The brain’s neurons are essential to thinking, walking, talking, and all human activity.
55 million people are living with Alzheimer’s disease and other dementias worldwide. An estimated 6.7 million Americans are living with Alzheimer’s dementia. As the number of Americans grows older, so too will the number of people diagnosed with Alzheimer’s increase.
Each September, the global community recognizes World Alzheimer’s Month, a time to raise awareness, challenge stigma, and encourage support for individuals and families affected by Alzheimer’s disease (AD). Alzheimer’s is the most common form of dementia, impacting memory, thinking, and behavior. More than 6 million Americans are currently living with Alzheimer’s, and that number is
𝗦𝗮𝘁𝘂𝗿𝗱𝗮𝘆, 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟮𝟭, 𝗶𝘀 𝗪𝗼𝗿𝗹𝗱 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗗𝗮𝘆, a global event dedicated to raising awareness about Alzheimer’s disease and other forms of dementia. It’s also a day to challenge the stigma that often surrounds these conditions, which can prevent people from seeking help or receiving the support they need. World Alzheimer’s Day offers an opportunity to
World Alzheimer’s Day: Raising Awareness and Challenging Stigma Read More »
Alzheimer’s disease is a progressive neurological disorder that affects millions of people worldwide, leading to memory loss, cognitive decline, and significant disruptions in daily life. It is the most common form of dementia, a general term for conditions characterized by a decline in cognitive abilities severe enough to interfere with daily activities. Despite its prevalence,
Alzheimer’s Disease Symptoms, Causes, and Treatments Read More »
According to Fiorillo, 2023, Alzheimer’s is a type of brain disease caused by damage to nerve cells known as neurons in the brain. Neurons transmit information throughout the human body. Using electrical and chemical signals, neurons direct all of the required functions of life, such as thinking, walking, talking, and all human activities. In Alzheimer’s,
Last week Eli Lilly and Company announced that nearly half of the participants on their early Alzheimer’s drug donanemab had no clinical progression at 1 year. The study showed donanemab treatment slowed clinical decline by 35% compared to placebo and resulted in 40% less decline in the ability to perform activities of daily living. Based
Donanemab Slowed Cognitive Decline in Lilly’s Phase 3 Alzheimer’s Study Read More »
